CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 13 of 18

Seminars in Arthritis and Rheumatism

Briefs 481–520 of 684 CurrentRheuma has covered from this journal, newest publication first

Latest from Seminars in Arthritis and Rheumatism

All coverage, newest first

  1. Semin Arthritis Rheum

    Eosinophilic giant cell arteritis: A different subset of disease?

    Cohort studyVasculitis & PMR

  2. Semin Arthritis Rheum

    Standardization of interstitial lung disease assessment by ultrasound: results from a Delphi process and web-reliability exercise by the OMERACT ultrasound working group

    Guideline or statementAcross diseases

  3. Semin Arthritis Rheum

    Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional study

    Cross-sectional studyPediatric

  4. Semin Arthritis Rheum

    Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from a randomized controlled trial

    Secondary analysisOsteoarthritis

  5. Semin Arthritis Rheum

    The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region

    Guideline or statementSpondyloarthritis & PsA

  6. Semin Arthritis Rheum

    Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies

    Cohort studyMyositis

  7. Semin Arthritis Rheum

    Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis

    Guideline or statementSpondyloarthritis & PsA

  8. Semin Arthritis Rheum

    Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group

    Research articleSystemic sclerosis

  9. Semin Arthritis Rheum

    Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis

    Guideline or statementOsteoarthritis

  10. Semin Arthritis Rheum

    Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group

    Research articleSjögren's & overlap

  11. Semin Arthritis Rheum

    Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies

    Meta-analysisFibromyalgia & pain

  12. Semin Arthritis Rheum

    Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

    Cohort studySpondyloarthritis & PsA

  13. Semin Arthritis Rheum

    Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases

    Cohort studyAcross diseases

  14. Semin Arthritis Rheum

    Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications

    Cohort studySystemic sclerosis

  15. Semin Arthritis Rheum

    The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation

    Research articleSjögren's & overlap

  16. Semin Arthritis Rheum

    PROMIS-29 in rheumatoid arthritis patients who screen positive or negative for fibromyalgia on MDHAQ FAST4 (fibromyalgia assessment screening tool) or 2011 fibromyalgia criteria

    Cross-sectional study

  17. Semin Arthritis Rheum

    Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

    Guideline or statement

  18. Semin Arthritis Rheum

    Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis

    Cross-sectional studyRA

  19. Semin Arthritis Rheum

    Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis

    Cohort studyRA

  20. Semin Arthritis Rheum

    Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies – A longitudinal study

    Cohort studyMyositis

  21. Semin Arthritis Rheum

    Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial

    Secondary analysisSystemic sclerosis

  22. Semin Arthritis Rheum

    OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set

    Guideline or statementLupus & APS

  23. Semin Arthritis Rheum

    Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis

    Meta-analysisFibromyalgia & pain

  24. Semin Arthritis Rheum

    KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)

    Cross-sectional studySystemic sclerosis

  25. Semin Arthritis Rheum

    Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea

    Cohort studyRA

  26. Semin Arthritis Rheum

    A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada

    Cohort studyAcross diseases

  27. Semin Arthritis Rheum

    Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative

    Guideline or statement

  28. Semin Arthritis Rheum

    An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare

    Meta-analysisGout & crystals

  29. Semin Arthritis Rheum

    Exposure to air pollutants and rheumatoid arthritis biomarkers: A scoping review

    Research articleRA

  30. Semin Arthritis Rheum

    Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis

    Cohort studyMyositis

  31. Semin Arthritis Rheum

    Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand – A retrospective cohort study

    Cohort studyRA

  32. Semin Arthritis Rheum

    High prevalence of diffuse idiopathic skeletal hyperostosis (DISH) among obese young patients – A retrospective observational study

    Cohort study

  33. Semin Arthritis Rheum

    Pediatric-onset Takayasu arteritis is associated with greater risk of mortality than adult-onset Takayasu arteritis–A systematic review with meta-analysis of observational cohort studies

    Meta-analysisPediatric

  34. Semin Arthritis Rheum

    Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study

    Cohort studyVasculitis & PMR

  35. Semin Arthritis Rheum

    Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Cohort studyLupus & APS

  36. Semin Arthritis Rheum

    OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments

    Research articlePediatric

  37. Semin Arthritis Rheum

    Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update

    Meta-analysisLupus & APS

  38. Semin Arthritis Rheum

    Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases

    Guideline or statementAcross diseases

  39. Semin Arthritis Rheum

    Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort

    Cohort studyVasculitis & PMR

  40. Semin Arthritis Rheum

    Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop

    Guideline or statement

All 684 Briefs in ExploreShowing Briefs 481–520 of 684, newest first